Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,161,207
-$36,578,571 QoQ
Shares Held
139,233
-41.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#143
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Sep 30, 2021CallValue
$217,668
CallShares
1,200
PutValue
$217,668
PutShares
1,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. VRTX ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in VRTX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,161,207 | 139,233 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $105,739,778 | 236,798 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $172,610,019 | 380,735 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $142,076,809 | 362,774 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $56,815,533 | 127,618 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,361,505 | 15,184 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $35,729,959 | 88,726 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $24,053,006 | 51,718 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $92,476,580 | 197,296 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $220,677,510 | 527,924 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $144,363,756 | 354,798 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $94,879,467 | 272,846 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $134,718,185 | 382,820 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $111,303,202 | 353,265 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $166,452,212 | 576,398 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $68,239,365 | 235,682 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,607,474 | 122,813 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $112,415,436 | 430,760 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $211,590,089 | 963,525 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $219,743,645 | 1,211,443 | Shares | Defined | 2021-11-15 | |
| 2021-09-30 | $217,668 | 1,200 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $217,668 | 1,200 | Put | Defined | 2021-11-15 | |
| 2021-06-30 | $169,394,201 | 840,124 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $136,962,718 | 637,362 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $219,302,485 | 927,911 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $193,268,331 | 710,232 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $171,989,804 | 592,435 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $158,950,600 | 668,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||